Sitemap
May 29, 2020 Articles
Filter by Available Specialty
- 10% of people with diabetes, COVID-19 die within 7 days of hospital admission
- ACS presentation may differ in women vs. men
- Adjuvant dabrafenib-trametinib provides ‘real chance to cure’ BRAF-mutant melanoma
- Adjuvant osimertinib extends DFS in EGFR-mutated NSCLC
- After-visit summaries for glaucoma medication vary in efficacy
- AstraZeneca donates $1.1 million to AKF’s COVID-19 emergency fund
- Automated detection of glaucoma biomarkers may predict progression
- Avelumab safe, effective for treatment of gestational trophoblastic tumors
- Blood test predicts preterm birth risk
- Breathing 'Rheum' in COVID-19 Hotspots: Detroit juggles poverty, protests, and possible resurgence
- Confirmed ischemic stroke rates low in COVID-19
- Dietary gluten does not increase Crohn’s, UC in women without celiac disease
- ESCRS congress will be held online due to COVID-19 pandemic
- FDA approves oral therapy for heavy menstrual bleeding associated with uterine fibroids
- FDA approves Tauvid, first drug to help image certain Alzheimer’s disease signal
- FDA approves topical foam for rosacea in adults
- FDA policy turns away thousands of potential cornea donations each year
- Few US adults participate in all recommended healthy behaviors
- Health care efficiency rises with EHR-based diabetes management model in Denmark
- Large study adds to questions about safety, usefulness of hydroxychloroquine for COVID-19
- LO2A studied for Sjögren-related dry eye symptoms
- Long-acting antipsychotics safe, effective for in-hospital schizophrenia therapy initiation
- Mobility program benefits hospitalized patients with cancer
- PAMORAs help achieve response in opioid-induced constipation
- Pembrolizumab doubles PFS for certain patients with metastatic colorectal cancer
- Pembrolizumab extends PFS in relapsed or refractory classical Hodgkin lymphoma
- Pembrolizumab plus axitinib prolongs survival in advanced renal cell carcinoma
- Pembrolizumab plus chemotherapy extends PFS in breast cancer subset
- Precision oncology approach confers clinical benefit in relapsed pediatric cancer
- Prior chemotherapy linked to mortality risk among patients with thoracic cancers, COVID-19
- Q&A: Remdesivir a ‘go-to’ COVID-19 treatment, but questions remain
- Q&A: Shared decision-making ‘extremely important’ in maternal care
- Q&A: Sun protection key in anti-aging, cancer prevention for skin of color
- Study identifies cardiopulmonary contributors to death in COVID-19
- Tibial tubercle osteotomy, medial patellofemoral ligament imbrication reduced instability
- Top 5 psychiatry stories of May
- Top in GI: COVID-19 and IBD, dose optimization in Crohn’s
- Universal health care may not fully solve inequities in access to kidney transplantation
- VIDEO: Allergy diagnosis requires close look at symptoms, environment, proteins
- WHO launches tobacco awareness kit for school-aged teens